View Archive »
About The Cover
Cytokeratin and vimentin/CD68 have a non-overlapping pattern of staining, while HGF and c-Met are expressed in both cancer and macrophage or stromal compartments. See Mariani et al.
|
|
Table of Contents
Editorial
|
| Tcell therapy against cancer mutations |
|
https://doi.org/10.18632/oncotarget.2234
|
| 4579-4580 |
Reviews
|
| Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A CIP2A: an oncoprotein with many hands |
|
https://doi.org/10.18632/oncotarget.2127
|
| 4581-4602 |
|
| Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention |
|
https://doi.org/10.18632/oncotarget.2209
|
| 4603-4650 |
Clinical Research Papers
|
| Characterization of tumorassociated Bcell subsets in patients with colorectal cancer |
|
https://doi.org/10.18632/oncotarget.1701
|
| 4651-4664 |
|
| Identification of kitM541L somatic mutation in chronic eosinophilic leukemia not otherwise specified and its implication in lowdose imatinib response |
|
https://doi.org/10.18632/oncotarget.1941
|
| 4665-4670 |
|
| Investigation of IL23 p19 p40 and IL23R identifies nuclear expression of IL23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients |
|
https://doi.org/10.18632/oncotarget.2069
|
| 4671-4682 |
|
| A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway |
|
https://doi.org/10.18632/oncotarget.2088
|
| 4683-4693 |
Research Papers
|
| High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression confer resistance to apoptosis and antagonize Myc effects on cell cycle |
|
https://doi.org/10.18632/oncotarget.2100
|
| 4694-4708 |
|
| Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by nintedanib a small molecule angiokinase inhibitor |
|
https://doi.org/10.18632/oncotarget.1671
|
| 4709-4721 |
|
| Capturing the metabolomic diversity of KRAS mutants in nonsmallcell lung cancer cells |
|
https://doi.org/10.18632/oncotarget.1958
|
| 4722-4731 |
|
| Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC1α signaling |
|
https://doi.org/10.18632/oncotarget.1963
|
| 4732-4745 |
|
| Metformin limits the adipocyte tumorpromoting effect on ovarian cancer |
|
https://doi.org/10.18632/oncotarget.2012
|
| 4746-4764 |
|
| Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells |
|
https://doi.org/10.18632/oncotarget.2017
|
| 4765-4778 |
|
| A polymorphism in JMJD2C alters the cleavage by caspase3 and the prognosis of human breast cancer |
|
https://doi.org/10.18632/oncotarget.2029
|
| 4779-4787 |
|
| Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancerassociated genes |
|
https://doi.org/10.18632/oncotarget.2033
|
| 4788-4798 |
|
| Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells |
|
https://doi.org/10.18632/oncotarget.2035
|
| 4799-4810 |
|
| Antitumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model |
|
https://doi.org/10.18632/oncotarget.2038
|
| 4811-4820 |
|
| MicroRNA31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2 |
|
https://doi.org/10.18632/oncotarget.2043
|
| 4821-4833 |
|
| Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients |
|
https://doi.org/10.18632/oncotarget.2044
|
| 4834-4844 |
|
| Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2045
|
| 4845-4854 |
|
| HGF/cMet axis drives cancer aggressiveness in the neoadjuvant setting of ovarian cancer |
|
https://doi.org/10.18632/oncotarget.2049
|
| 4855-4867 |
|
| Afatinib and its encapsulated polymeric micelles inhibits HER2overexpressed colorectal tumor cell growth in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.2050
|
| 4868-4880 |
|
| Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells |
|
https://doi.org/10.18632/oncotarget.2051
|
| 4881-4894 |
|
| Tumorderived CXCL8 signaling augments stromaderived CCL2promoted proliferation and CXCL12mediated invasion of PTENdeficient prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.2052
|
| 4895-4908 |
|
| RFX1–dependent activation of SHP1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cells |
|
https://doi.org/10.18632/oncotarget.2054
|
| 4909-4919 |
|
| Receptor ligandtriggered resistance to alectinib and its circumvention by Hsp90 inhibition in EML4ALK lung cancer cells |
|
https://doi.org/10.18632/oncotarget.2055
|
| 4920-4928 |
|
| Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR2/PI3K/mTOR pathway in ovarian cancer xenografts |
|
https://doi.org/10.18632/oncotarget.2063
|
| 4929-4934 |
|
| The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR2/Akt/mTOR signaling and VEGF and HIF1α expression |
|
https://doi.org/10.18632/oncotarget.2064
|
| 4935-4944 |
|
| Engineered ubiquitin ligase PTBUbox targets insulin/insulinlike growth factor receptor for degradation and coordinately inhibits cancer malignancy |
|
https://doi.org/10.18632/oncotarget.2066
|
| 4945-4958 |
|
| miR942 decreases TRAILinduced apoptosis through ISG12a downregulation and is regulated by AKT |
|
https://doi.org/10.18632/oncotarget.2067
|
| 4959-4971 |
|
| Silibinin strongly inhibits the growth kinetics of colon cancer stem cellenriched spheroids by modulating interleukin 4/6mediated survival signals |
|
https://doi.org/10.18632/oncotarget.2068
|
| 4972-4989 |
|
| Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma |
|
https://doi.org/10.18632/oncotarget.2071
|
| 4990-5001 |
|
| Yin Yang 1 is a target of microRNA34 family and contributes to gastric carcinogenesis |
|
https://doi.org/10.18632/oncotarget.2073
|
| 5002-5016 |
|
| GCIP functions as a tumor suppressor in nonsmall cell lung cancer by suppressing Id1mediated tumor promotion |
|
https://doi.org/10.18632/oncotarget.2075
|
| 5017-5028 |
|
| Sulfatase 1 hSulf1 reverses basic fibroblast growth factorstimulated signaling and inhibits growth of hepatocellular carcinoma in animal model |
|
https://doi.org/10.18632/oncotarget.2078
|
| 5029-5039 |
|
| The MAPK pathway as an apoptosis enhancer in melanoma |
|
https://doi.org/10.18632/oncotarget.2079
|
| 5040-5053 |
|
| Insights from yeast into whether the rapamycin inhibition of heat shock transcription factor Hsf1 can prevent the Hsf1 activation that results from treatment with an Hsp90 inhibitor |
|
https://doi.org/10.18632/oncotarget.2077
|
| 5054-5064 |
|
| Mutational analysis of primary central nervous system lymphoma |
|
https://doi.org/10.18632/oncotarget.2080
|
| 5065-5075 |
|
| Niraparib MK4827 a novel polyADPRibose polymerase inhibitor radiosensitizes human lung and breast cancer cells |
|
https://doi.org/10.18632/oncotarget.2083
|
| 5076-5086 |
|
| Visfatin promotes cell and tumor growth by upregulating Notch1 in breast cancer |
|
https://doi.org/10.18632/oncotarget.2086
|
| 5087-5099 |
|
| Targeting the KRas JNK axis eliminates cancer stemlike cells and prevents pancreatic tumor formation |
|
https://doi.org/10.18632/oncotarget.2087
|
| 5100-5112 |
|
| FoxD3regulated microRNA137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2 |
|
https://doi.org/10.18632/oncotarget.2089
|
| 5113-5124 |
|
| HRas regulation of TRAIL death receptor mediated apoptosis |
|
https://doi.org/10.18632/oncotarget.2091
|
| 5125-5137 |
|
| ERBB3 knockdown induces cell cycle arrest and activation of Bak and Baxdependent apoptosis in colon cancer cells |
|
https://doi.org/10.18632/oncotarget.2094
|
| 5138-5152 |
|
| The subcellular distribution and function of MTA1 in cancer differentiation |
|
https://doi.org/10.18632/oncotarget.2095
|
| 5153-5164 |
|
| RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth |
|
https://doi.org/10.18632/oncotarget.2099
|
| 5165-5176 |
|
| Inhibition of glucose turnover by 3bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine |
|
https://doi.org/10.18632/oncotarget.2120
|
| 5177-5189 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
